Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM8 | O00222 | 2/20 | 0.82 |
| ▸ | GRM6 | O15303 | 2/20 | 0.82 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.82 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.82 |
| ▸ | GSR | P00390 | 2/20 | 0.82 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.82 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.82 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.82 |
| ▸ | GRM5 | P41594 | 1/20 | 0.82 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.82 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.82 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.82 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.82 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.82 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.82 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.82 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.82 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.82 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL910530 | 1.00 | GRM8 (0.82) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL27867309 | 0.98 | GRM8 (0.78) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL5053703 | 0.91 | GRM8 (0.82) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL27856487 | 0.91 | GRM8 (0.82) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL1332297 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL1554237 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL1330484 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL248800 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL1330824 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL410241 | 0.91 | GRM8 (1.00) | GRM8GRM6GRM7GRM4GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120188854-A | Nutritional feed based on urea and application of nutritional feed in ruminants | 云南牛牛牧业股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-117512596-A | Tin-copper-titanium etching solution | 湖北兴福电子材料股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| WO-2023167563-A1 | COMPOSITION CONTAINING N-CARBAMYL-L-GLUTAMIC ACID FOR TREATMENT OF INFLAMMATORY DISEASES | 한국생명공학연구원 | 2023-09-07 | — | — | WO | claimed |
| CN-108165522-B | Embryonic-period supplement for improving quality of broiler chickens and promoting early growth and application thereof | 中国农业科学院饲料研究所 | 2020-12-01 | — | — | CN | claimed |
| CN-101481336-A | Preparation of N-carbamoyl-aminoglutaric acid and sodium salt thereof | UNIV NANCHANG (CN) | 2009-07-15 | — | — | CN | claimed |
| WO-2008116165-A9 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY INC (US) | 2009-06-11 | — | — | WO | claimed |
| WO-2008116165-A2 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| CN-121063963-B | Yield-increasing liquid fertilizer containing enzymolysis clamworm and preparation method thereof | 沈阳华清源农业发展有限公司 | 2026-02-10 | — | — | CN | disclosed |
| CN-121063963-A | Efficient yield-increasing liquid fertilizer containing enzymolysis clamworm and preparation method thereof | 沈阳华清源农业发展有限公司 | 2025-12-05 | — | — | CN | disclosed |
| CN-120188854-A | Nutritional feed based on urea and application of nutritional feed in ruminants | 云南牛牛牧业股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119605730-A | Method for improving chick shell emergence weight and promoting early growth and development and application | 山东农业大学 | 2025-03-14 | — | — | CN | disclosed |
| US-12194031-B2 | Compounds for use in regulating follicle maturation | AARHUS UNIVERSITET (DK) | 2025-01-14 | — | — | US | disclosed |
| EP-4129285-B1 | COMPOUNDS FOR USE IN REGULATING FOLLICLE MATURATION | UNIV AARHUS (DK) | 2024-11-20 | — | — | EP | disclosed |
| CN-101969920-A | Parakeratosis inhibitor, pore shrinking agent or agent for preventing or improving rough skin, and composition for external use on the skin containing the same | SHISEIDO CO LTD | 2011-02-09 | — | — | CN | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
| CN-101481336-A | Preparation of N-carbamoyl-aminoglutaric acid and sodium salt thereof | UNIV NANCHANG (CN) | 2009-07-15 | — | — | CN | disclosed |
| US-20080066741-A1 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | HUNTER, CHARLES ERIC | 2008-03-20 | — | — | US | disclosed |
| EP-0029000-A1 | Mixed salts of an alkaline earth metal and of dimethylamino ethanol of N-acyl-glutamic acids and N-acyl-aspartic acids | INTERCO S.A. (CH) | 1981-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | CUTA, GLRA3, ARGLU1 | GRM8 513/4885GRM6 1035/4885GRM7 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.